APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non Receptor Tyrosine Protein Kinase TYK2

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non Receptor Tyrosine Protein Kinase TYK2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025183 pages

Choose your research edition.

Industry ResearchNon Receptor Tyrosine Protein Kinase TYK2 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Receptor Tyrosine Protein Kinase TYK2 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non Receptor Tyrosine Protein Kinase TYK2 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non Receptor Tyrosine Protein Kinase TYK2 include Takeda Pharmaceutical Company Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Theravance Biopharma Inc, Sareum Holdings Plc, Portola Pharmaceuticals Inc, Nimbus Therapeutics LLC and Array BioPharma Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non Receptor Tyrosine Protein Kinase TYK2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non Receptor Tyrosine Protein Kinase TYK2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non Receptor Tyrosine Protein Kinase TYK2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non Receptor Tyrosine Protein Kinase TYK2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Company

Takeda Pharmaceutical Company Ltd

Pfizer Inc

Bristol-Myers Squibb Company

Theravance Biopharma Inc

Sareum Holdings Plc

Portola Pharmaceuticals Inc

Nimbus Therapeutics LLC

Array BioPharma Inc

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Type

ARRY-624

BMS-986165

NDI-031232

Cerdulatinib

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Application

Follicular Lymphoma

Lupus Nephritis

Hypersensitivity

Marginal Zone B-cell Lymphoma

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Receptor Tyrosine Protein Kinase TYK2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Receptor Tyrosine Protein Kinase TYK2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Receptor Tyrosine Protein Kinase TYK2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non Receptor Tyrosine Protein Kinase TYK2 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non Receptor Tyrosine Protein Kinase TYK2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non Receptor Tyrosine Protein Kinase TYK2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non Receptor Tyrosine Protein Kinase TYK2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends Table 2. Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers Table 3. Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges Table 4. Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints Table 5. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Manufacturers Table 9. Global Non Receptor Tyrosine Protein Kinase TYK2 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Non Receptor Tyrosine Protein Kinase TYK2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non Receptor Tyrosine Protein Kinase TYK2 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers, Product Type & Application Table 13. Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non Receptor Tyrosine Protein Kinase TYK2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ARRY-624 Table 17. Major Manufacturers of BMS-986165 Table 18. Major Manufacturers of NDI-031232 Table 19. Major Manufacturers of Cerdulatinib Table 20. Major Manufacturers of Others Table 21. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 23. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 24. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2026) Table 25. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2027-2032) Table 26. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (K Units) Table 28. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (K Units) Table 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2026) Table 30. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Follicular Lymphoma Table 32. Major Manufacturers of Lupus Nephritis Table 33. Major Manufacturers of Hypersensitivity Table 34. Major Manufacturers of Marginal Zone B-cell Lymphoma Table 35. Major Manufacturers of Others Table 36. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 38. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 39. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2026) Table 40. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2027-2032) Table 41. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (K Units) Table 43. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (K Units) Table 44. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2026) Table 45. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2027-2032) Table 46. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2026) & (K Units) Table 48. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2021-2026) Table 49. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 53. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 54. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 56. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 63. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2021-2026) Table 67. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2027-2032) Table 68. Takeda Pharmaceutical Company Ltd Company Information Table 69. Takeda Pharmaceutical Company Ltd Business Overview Table 70. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 72. Takeda Pharmaceutical Company Ltd Recent Development Table 73. Pfizer Inc Company Information Table 74. Pfizer Inc Business Overview Table 75. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 77. Pfizer Inc Recent Development Table 78. Bristol-Myers Squibb Company Company Information Table 79. Bristol-Myers Squibb Company Business Overview Table 80. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 82. Bristol-Myers Squibb Company Recent Development Table 83. Theravance Biopharma Inc Company Information Table 84. Theravance Biopharma Inc Business Overview Table 85. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 87. Theravance Biopharma Inc Recent Development Table 88. Sareum Holdings Plc Company Information Table 89. Sareum Holdings Plc Business Overview Table 90. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 92. Sareum Holdings Plc Recent Development Table 93. Portola Pharmaceuticals Inc Company Information Table 94. Portola Pharmaceuticals Inc Business Overview Table 95. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 97. Portola Pharmaceuticals Inc Recent Development Table 98. Nimbus Therapeutics LLC Company Information Table 99. Nimbus Therapeutics LLC Business Overview Table 100. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 102. Nimbus Therapeutics LLC Recent Development Table 103. Array BioPharma Inc Company Information Table 104. Array BioPharma Inc Business Overview Table 105. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 107. Array BioPharma Inc Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Non Receptor Tyrosine Protein Kinase TYK2 Distributors List Table 111. Non Receptor Tyrosine Protein Kinase TYK2 Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Non Receptor Tyrosine Protein Kinase TYK2 Product Image Figure 2. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales (2021-2032) & (K Units) Figure 5. Global Non Receptor Tyrosine Protein Kinase TYK2 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non Receptor Tyrosine Protein Kinase TYK2 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ARRY-624 Image Figure 9. BMS-986165 Image Figure 10. NDI-031232 Image Figure 11. Cerdulatinib Image Figure 12. Others Image Figure 13. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2032) Figure 16. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2032) Figure 19. Follicular Lymphoma Image Figure 20. Lupus Nephritis Image Figure 21. Hypersensitivity Image Figure 22. Marginal Zone B-cell Lymphoma Image Figure 23. Others Image Figure 24. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2032) Figure 27. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2032) Figure 30. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 32. U.S. Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 37. Germany Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 44. China Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 52. Brazil Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Non Receptor Tyrosine Protein Kinase TYK2 Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Figure 63. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Figure 65. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Non Receptor Tyrosine Protein Kinase TYK2 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • ARRY-624
  • BMS-986165
  • NDI-031232
  • Cerdulatinib
  • Others
Applications
  • Follicular Lymphoma
  • Lupus Nephritis
  • Hypersensitivity
  • Marginal Zone B-cell Lymphoma
  • Others
Companies covered
  • Takeda Pharmaceutical Company Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Theravance Biopharma Inc
  • Sareum Holdings Plc
  • Portola Pharmaceuticals Inc
  • Nimbus Therapeutics LLC
  • Array BioPharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Dynamics
  1. 2.1 Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends
  2. 2.2 Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers
  3. 2.3 Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges
  4. 2.4 Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints
3 Non Receptor Tyrosine Protein Kinase TYK2 Market by Manufacturers
  1. 3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non Receptor Tyrosine Protein Kinase TYK2 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers, Product Type & Application
  7. 3.7 Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non Receptor Tyrosine Protein Kinase TYK2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non Receptor Tyrosine Protein Kinase TYK2 Tier 1, Tier 2, and Tier 3
4 Non Receptor Tyrosine Protein Kinase TYK2 Market by Type
  1. 4.1 Non Receptor Tyrosine Protein Kinase TYK2 Type Introduction
  2. 4.1.1 ARRY-624
  3. 4.1.2 BMS-986165
  4. 4.1.3 NDI-031232
  5. 4.1.4 Cerdulatinib
  6. 4.1.5 Others
  7. 4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type
  8. 4.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032)
  10. 4.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type
  12. 4.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032)
  14. 4.3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2032)
5 Non Receptor Tyrosine Protein Kinase TYK2 Market by Application
  1. 5.1 Non Receptor Tyrosine Protein Kinase TYK2 Application Introduction
  2. 5.1.1 Follicular Lymphoma
  3. 5.1.2 Lupus Nephritis
  4. 5.1.3 Hypersensitivity
  5. 5.1.4 Marginal Zone B-cell Lymphoma
  6. 5.1.5 Others
  7. 5.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application
  8. 5.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032)
  10. 5.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application
  12. 5.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032)
  14. 5.3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2032)
6 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region
  1. 6.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2032)
  3. 6.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2026)
  4. 6.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region
  1. 7.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region
  2. 7.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2021-2026)
  4. 7.1.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2027-2032)
  5. 7.1.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032)
  8. 7.2.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032)
  11. 7.3.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company Ltd
  2. 8.1.1 Takeda Pharmaceutical Company Ltd Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Ltd Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Ltd Recent Developments
  7. 8.2 Pfizer Inc
  8. 8.2.1 Pfizer Inc Company Information
  9. 8.2.2 Pfizer Inc Business Overview
  10. 8.2.3 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  12. 8.2.5 Pfizer Inc Recent Developments
  13. 8.3 Bristol-Myers Squibb Company
  14. 8.3.1 Bristol-Myers Squibb Company Company Information
  15. 8.3.2 Bristol-Myers Squibb Company Business Overview
  16. 8.3.3 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 8.4 Theravance Biopharma Inc
  20. 8.4.1 Theravance Biopharma Inc Company Information
  21. 8.4.2 Theravance Biopharma Inc Business Overview
  22. 8.4.3 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  24. 8.4.5 Theravance Biopharma Inc Recent Developments
  25. 8.5 Sareum Holdings Plc
  26. 8.5.1 Sareum Holdings Plc Company Information
  27. 8.5.2 Sareum Holdings Plc Business Overview
  28. 8.5.3 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  30. 8.5.5 Sareum Holdings Plc Recent Developments
  31. 8.6 Portola Pharmaceuticals Inc
  32. 8.6.1 Portola Pharmaceuticals Inc Company Information
  33. 8.6.2 Portola Pharmaceuticals Inc Business Overview
  34. 8.6.3 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  36. 8.6.5 Portola Pharmaceuticals Inc Recent Developments
  37. 8.7 Nimbus Therapeutics LLC
  38. 8.7.1 Nimbus Therapeutics LLC Company Information
  39. 8.7.2 Nimbus Therapeutics LLC Business Overview
  40. 8.7.3 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  42. 8.7.5 Nimbus Therapeutics LLC Recent Developments
  43. 8.8 Array BioPharma Inc
  44. 8.8.1 Array BioPharma Inc Company Information
  45. 8.8.2 Array BioPharma Inc Business Overview
  46. 8.8.3 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  48. 8.8.5 Array BioPharma Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Analysis
  2. 9.1.1 Non Receptor Tyrosine Protein Kinase TYK2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non Receptor Tyrosine Protein Kinase TYK2 Production Mode & Process
  6. 9.2 Non Receptor Tyrosine Protein Kinase TYK2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non Receptor Tyrosine Protein Kinase TYK2 Distributors
  9. 9.2.3 Non Receptor Tyrosine Protein Kinase TYK2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst